Skip to content

Carotid artery stenting during endovascular treatment of acute ischemic stroke

Carotid Artery Stenting during Endovascular treatment of acute ischemic Stroke: a randomized multicenter clinical trial in patients with acute ischemic stroke and carotid artery stenosis undergoing endovascular treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14956654
Enrollment
600
Registered
2023-01-18
Start date
2023-06-19
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke in patients with large vessel occlusion in the anterior circulation and a concommitant high grade ipsilateral carotid artery stenosis or occlusion of presumed atherosclerotic origin.. Circulatory System

Interventions

Patients with an ipsilateral high grade carotid artery stenosis or occlusion of presumed atherosclerotic origin and an proximal intracranial large vessel occlusion in the anterior circulation will be

Sponsors

University Medical Center Groningen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 130 Years

Inclusion criteria

Inclusion criteria: 1. Acute ischemic stroke due to proximal intracranial occlusion in the anterior circulation (intracranial ICA, M1, proximal M2) on the CT angiography 2. Stenosis >50% according to the NASCET criteria16 or initial occlusion of the ipsilateral cervical carotid artery of presumed atherosclerotic origin on baseline CT angiography 3. Eligible for EVT according to the guidelines: EVT within 6 hours of onset or EVT between 6-24 hours after onset based on perfusion CT imaging selection (conform current guidelines) 4. Baseline National Institute of Health Stroke Scale (NIHSS) score =2 5. Age >18 years 6. Written informed consent (deferred consent)

Exclusion criteria

Exclusion criteria: 1. Any intracranial hemorrhage 2. Cervical carotid artery stenosis or occlusion with other causes than presumed atherosclerosis (e.g. carotid artery dissection, floating thrombus, carotid web) 3. Any exclusion criterion for EVT according to the guidelines 4. Pre stroke disability (defined as a modified Rankin Scale score >2) 5. Recent gastro-intestinal or urinary tract hemorrhage (<6 weeks) 6. Recent severe head trauma (<6 weeks) 7. Recent infarction on baseline brain CT in the same vascular territory (<6 weeks) 8. Known allergy to aspirin and/or clopidogrel 9. Pregnancy

Design outcomes

Primary

MeasureTime frame
Stroke-related disability measured using the Modified Rankin Scale (mRS) Score at 90 days after stroke onset.The mRS score will be assessed by stroke research personnel by telephone interview, blinded for the treatment allocation

Secondary

MeasureTime frame
1. NIHSS score at 24 hours and day 5-7, or at discharge (Medical examination) 2. Adequate recanalization after EVT (TICI 2b or higher) (Review of performed imaging) 3. Final infarct volume on brain CT at 24 hours (Review of performed imaging) 4. Arterial occlusive lesion (AOL) score on CTA at 24 hours (Review of performed imaging) 5. Any stroke within 90 days (Obtained from medical records) 6. Recurrent ipsilateral TIA/ischemic stroke within 90 days 7. Carotid artery re-occlusion at 24 hours and 90 days (Review of performed imaging) 8. Mortality at 90 days (Obtained from medical records) 9. Quality of life (EQ5D-5L) questionnaire at 90 days

Countries

Belgium, Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 7, 2026